talazoparib,enzalutamide
astellas,pfizer
['gu ', 'talzenna', 'xtandi', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
the median radiographic progression-free survival was not reached in the #talzenna + #xtandi arm versus 21.9 months in the #placebo + #xtandi arm. #gu23 #ascogu23 #ascogu #asco #cancer #oncology #ascodailynews
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma